Question 10.2: In your opinion, do you think guidance material to monitor patients with a high risk for lung cancer would be beneficial? Table 10.2: Statistical results Statistical results Frequency Percent No 23 15.34 Yes 92 61.33 Not answered 35 23.33 Total 150 100 Figure 10.2 Benefits of developing guidance materials for monitoring high risk patients Question 11.1: From your experience please indicate your level of agreement of the influence of the following factors on the effective TREATMENT of lung cancer Table 11.1: Statistical results to up to palliative oncological surgical delays delays Specialist team results risk in in in in guidance / follow services at oncology intervention reluctance to professional to to distance Statistical materials Medical Access Radiotherapy Access Variations Variations Variations Variations Treatment Treatment patients Surgical delays Patient care Failure Long specialist care travel treatment treatment radiotherapy intervention intervention N - Valid 106 106 106 106 106 105 106 107 106 107 107 106 106 104 N - Missing 27 27 27 27 27 28 27 26 27 26 26 27 27 29 Mean 5.86 6.11 5.46 6.03 5.29 4.85 5.59 6.74 5.61 5.22 5.31 5.20 5.16 5.12 Median 6.00 6.00 5.00 6.00 5.00 5.00 6.00 7.00 5.50 5.00 5.00 5.00 5.00 5.00 Std. Deviation 2.223 2.273 2.318 1.954 2.125 2.152 2.441 2.169 2.569 2.312 2.349 2.188 2.057 2.101 Percentiles - 25 4.00 5.00 4.00 5.00 3.00 3.00 3.75 5.00 3.00 3.00 3.00 3.00 3.00 3.00 Percentiles - 50 6.00 6.00 5.00 6.00 5.00 5.00 6.00 7.00 5.50 5.00 5.00 5.00 5.00 5.00 Percentiles - 75 8.00 8.00 7.00 8.00 7.00 6.00 8.00 9.00 8.00 7.00 7.00 7.00 6.00 7.00 Figure 11.1: Factors influencing the effective treatment of lung cancer 11.1 Open-ended Comment:
Question 10.2: In your opinion, do you think guidance material to monitor patients with a high risk for lung cancer would be beneficial? Table 10.2: Statistical results Statistical results Frequency Percent No 23 15.34 Yes 92 61.33 Not answered 35 23.33 Total 150 100 Figure 10.2 Benefits of developing guidance materials for monitoring high risk patients Question 11.1: From your experience please indicate your level of agreement of the influence of the following factors on the effective TREATMENT of lung cancer Table 11.1: Statistical results Statistical results Treatment Treatment professional Access to guidance materials / Specialist care Failure to follow up patients at risk Surgical intervention delays Medical oncology intervention delays Radiotherapy intervention delays Long distance to specialist services Access to team Patient reluctance to travel Variations in palliative care Variations in surgical treatment Variations in oncological treatment Variations in radiotherapy N - Valid 106 106 106 106 106 105 106 107 106 107 107 106 106 104 N - Missing 27 27 27 27 27 28 27 26 27 26 26 27 27 29 Mean 5.86 6.11 5.46 6.03 5.29 4.85 5.59 6.74 5.61 5.22 5.31 5.20 5.16 5.12 Median 6.00 6.00 5.00 6.00 5.00 5.00 6.00 7.00 5.50 5.00 5.00 5.00 5.00 5.00 Std. Deviation 2.223 2.273 2.318 1.954 2.125 2.152 2.441 2.169 2.569 2.312 2.349 2.188 2.057 2.101 Percentiles - 25 4.00 5.00 4.00 5.00 3.00 3.00 3.75 5.00 3.00 3.00 3.00 3.00 3.00 3.00 Percentiles - 50 6.00 6.00 5.00 6.00 5.00 5.00 6.00 7.00 5.50 5.00 5.00 5.00 5.00 5.00 Percentiles - 75 8.00 8.00 7.00 8.00 7.00 6.00 8.00 9.00 8.00 7.00 7.00 7.00 6.00 7.00 Figure 11.1: Factors influencing the effective treatment of lung cancer 11.1 Open-ended Comment: